Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2010
05/27/2010US20100129839 Method for in vitro diagnosis of pvl-producing staphylococcus aureus
05/27/2010US20100129838 Methods for prediction of inflammatory bowel disease (ibd) using serologic markers
05/27/2010US20100129837 Methods of capturing bacterial whole cells and methods of analyzing samples for bacteria
05/27/2010US20100129836 System for detecting bacteria in blood, blood products, and fluids of tissues
05/27/2010US20100129835 Methods for Selecting Improved Strains
05/27/2010US20100129834 Autoimmune regulation of prostate cancer by annexin a3
05/27/2010US20100129833 Methods to Identify Modulators
05/27/2010US20100129832 Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes
05/27/2010US20100129831 Methods for diagnosing hypersensitivity reactions
05/27/2010US20100129830 Label Independent Detection Biosensor Composition and Methods Thereof
05/27/2010US20100129829 Use of plasma hsp90 related to malignancy
05/27/2010US20100129828 Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer
05/27/2010US20100129826 Double stranded RNA receptor (dsRNA-R) and methods relating thereto
05/27/2010US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
05/27/2010US20100129814 Method for separation and characterization of microorganisms using identifier agents
05/27/2010US20100129813 Compositions and methods for detecting food-borne pathogens
05/27/2010US20100129809 INHIBITORS OF Rv0256c
05/27/2010US20100129806 Regulation of cell survival by hsp90 and ip6k2
05/27/2010US20100129804 Spink1 as a prostate cancer marker and uses thereof
05/27/2010US20100129795 Agents and methods for spectrometric analysis
05/27/2010US20100129794 Magnetic Polymer Particles
05/27/2010US20100129793 Composite particles
05/27/2010US20100129791 cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product
05/27/2010US20100129787 Agents and methods for spectrometric analysis
05/27/2010US20100129786 Agents and methods for spectrometric analysis
05/27/2010US20100129785 Agents and methods for spectrometric analysis
05/27/2010US20100129502 Food tray device and method
05/27/2010US20100129499 Breads
05/27/2010US20100129438 Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA
05/27/2010US20100129409 Novel Prostate Kallikrein Allergen
05/27/2010US20100129391 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
05/27/2010US20100129388 Protective proteins of s. agalactiae, combinations thereof and methods of using the same
05/27/2010US20100129387 Pharmaceutical composition containing the nmb0606 protein
05/27/2010US20100129386 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support
05/27/2010US20100129378 Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
05/27/2010US20100129376 Osteopontin Specific Antibodies and Methods of Use Thereof
05/27/2010US20100129374 Mammalian Cell Membrane Proteins; Related Reagents
05/27/2010US20100129367 Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
05/27/2010US20100129360 Antibodies against human interleukin-13 and uses therefor
05/27/2010US20100129346 Anti-C5aR Antibodies With Improved Properties
05/27/2010US20100129345 Screening method for prokinetic agent
05/27/2010US20100129336 Stabilized bacterial formulation
05/27/2010US20100129318 Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses
05/27/2010US20100129312 Infant formula containing an aroma composition for use as fragrance
05/27/2010US20100129291 Nicotinic desensitizers and methods of selecting, testing, and using them
05/27/2010US20100129289 Compositions and methods for the detection of vulnerable plaque
05/27/2010US20100127165 Mass spectromety with selective ion filtration by digital thresholding
05/27/2010US20100126911 Method For Using Native Bitumen Markers To Improve Solvent-Assisted Bitumen Extraction
05/27/2010US20100126884 Analyte Sensor with Insertion Monitor, and Methods
05/27/2010US20100126862 Multichannel preparative electrophoresis system
05/27/2010US20100126856 Analyte Test Instrument Having Improved Versatility
05/27/2010US20100126287 Pharmaceutical analysis apparatus and method
05/27/2010US20100126253 Method for determining the alcohol concentration of fuel that can be fed to combustion in a motor vehicle
05/27/2010DE202010002407U1 Testkoffer zur einfachen Bestimmung des Capsaicin-Gehalts von Lebensmitteln Test case for the simple determination of the capsaicin content in food
05/27/2010DE202010001404U1 Schablone für Petrischalen Template for Petri dishes
05/27/2010DE102009044594A1 Drahtloses Gerät zur Messung des Chloridgehalts im Schweiß für die Anwendung bei der Erkennung von zystischer Fibrose Wireless device to measure the chloride content in the welding for use in the detection of cystic fibrosis
05/27/2010DE102008058514A1 Screening device for estimation/prediction of e.g. solubility characteristics, of pharmaceutical substance in pharmaceutical industry, has distribution/mixing mechanism that is formed and dimensioned to immerse in release volumes
05/27/2010DE102008057866A1 Sample device for stool samples, has cap part with cone-shaped sealing attachment piece inserted into insertion opening of casing under flexible expansion, where attachment piece is brought into sealing contact with inner wall of casing
05/27/2010DE102008053909A1 Gasdetektor Gas detector
05/27/2010CA2744434A1 Methods, devices and kits for detecting or monitoring acute kidney injury
05/27/2010CA2744340A1 Method of determining pegylated blood coagulation factor activity in a silica-based activated partial thromboplastin time assay
05/27/2010CA2744331A1 Analyte detection assay
05/27/2010CA2744251A1 Salmonella marker vaccine
05/27/2010CA2744151A1 Metabolic syndrome and hpa axis biomarkers for major depressive disorder
05/27/2010CA2744003A1 Biosensor for detecting multiple epitopes on a target
05/27/2010CA2743907A1 Methods of determining polydispersity and/or molecular weight distribution of a polyethylene glycol sample
05/27/2010CA2743570A1 Method for determining the risk of pre-eclampsia
05/27/2010CA2743244A1 Semiconductor nanoparticle-based light emitting devices and associated materials and methods
05/27/2010CA2742792A1 Prediction and prevention of preeclampsia
05/26/2010EP2189793A1 Method for regenerating a biosensor
05/26/2010EP2189792A2 Apparatus for separating and/or analysing several molecular targets in a solution in a complex mixture
05/26/2010EP2189791A2 Microarrays and uses therefor
05/26/2010EP2189790A1 Method for quantification of titer of neurotoxin-neutralizing antibody
05/26/2010EP2189789A1 Method and device for checking the freshness of a fish
05/26/2010EP2189788A1 Method for quantification of steroid hormone
05/26/2010EP2189783A1 Waveguide grid structure and optical measuring assembly
05/26/2010EP2189779A2 Measuring element, device for fabrication of at least one measuring element; storage and coding device for at least one measuring element
05/26/2010EP2189537A1 Detection and treatment of schizophrenia
05/26/2010EP2189527A1 Cancer diagnosis kit and cancer diagnosis method
05/26/2010EP2189526A1 Antibody binding specifically to tdp-43 aggregate
05/26/2010EP2189523A1 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives
05/26/2010EP2189503A1 Novel nucleic acid derivative into which given compound has been introduced and method for producing the same
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189470A1 Tumor antigens
05/26/2010EP2189468A1 Method for modification of nucleotides in nucleic acid, and nucleic acid having modified nucleotide therein
05/26/2010EP2189220A1 Vessel for nucleic acid analysis
05/26/2010EP2189166A1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
05/26/2010EP2189164A1 Salmonella marker vaccine
05/26/2010EP2189162A1 Methods for the treatment of cellular proliferative disorders
05/26/2010EP2188636A1 Differentiation of different causes of right heart failure
05/26/2010EP2188635A1 Quantification of analytes using accelerator mass spectrometry
05/26/2010EP2188634A1 Fluorescence resonance energy transfer detection with nanoparticles
05/26/2010EP2188633A1 Detecting hepatitis b virus
05/26/2010EP2188632A1 Bacterial vaginosis apparatus and diagnostic methods
05/26/2010EP2188631A1 Antigen exposing micelle and unordered aggregate
05/26/2010EP2188630A2 Methods and compositions related to synergistic responses to oncogenic mutations
05/26/2010EP2188629A1 Native gp41 assay
05/26/2010EP2188628A2 Improved quality assurance system and method for point-of-care testing
05/26/2010EP2188627A1 Test strip container
05/26/2010EP2188625A1 Method and device for determining the chemical oxygen requirement of water or waste water